After the interest received by the previous seven editions and the excellent feed-back from the attendants, the 9th edition of the ACT course will be organized by the ESACT (European Society of Animal Cell Technology) in Llafranc, Costa Brava/Spain. ESACT is presenting this activity as one more contribution to the community involved in the use of animal cells in Biotechnology and Biomedicine.

The course is planned in an intensive four-day schedule with a number of participants limited to 30 in order to facilitate the interaction among them and with the lecturers. A limited number of grants, covering the course fee (not travel cost), are provided by ESACT. Applicants to the grants should indicate it in the course application, together with a motivation statement. Priority will be given to young PhD students from Academia. Lecturers will stay for most of the course duration. The course comprises lectures covering the main topics of Animal Cell Technology:

• Cell line development
• Cellular mechanisms
• Genomics and proteomics
• Post-translational modifications
• Bioreactor scale-up, scale down and single use bioreactor
• Downstream processing
• Integrated bioprocess for cell based vaccines
• Economical aspects of ACT bioprocesses
• Integrated bioprocess for protein production
• Integrated bioprocess for stem cells
• Industrial perspectives of ACT

The program has slots dedicated to the preparation and presentation of case studies by participants, and discussion groups with the lecturers.

Inquired speakers: Terry Papoutsakis (University Delaware, USA), Manuel Carrondo and Paula Alves (iBET, Portugal), Hansjörg Hauser (HZI, Germany), Francesc Gòdia (UAB, Spain), Nicole Borth (Boku, Austria), Stefanos Grammatikos (UCB Pharma SA, Belgium) and Anne Tolstrup (Biogen, Denmark).

Download flyer with detailed information: ESACT Flyer ACT-Course 2019 →